Total Payments
$301,766
2023 Payments
$49,243
Companies
40
Transactions
338
Payment Breakdown by Category
Consulting$219,932 (72.9%)
Travel$51,644 (17.1%)
Other$21,636 (7.2%)
Food & Beverage$8,553 (2.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $219,932 | 77 | 72.9% |
| Travel and Lodging | $51,644 | 125 | 17.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $16,736 | 7 | 5.5% |
| Food and Beverage | $8,553 | 127 | 2.8% |
| Honoraria | $4,900 | 2 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| EMD Serono, Inc. | $30,915 | 21 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $21,570 | 32 | $0 (2019) |
| NOVARTIS PHARMACEUTICALS CORPORATION | $20,479 | 22 | $0 (2023) |
| Eli Lilly and Company | $20,445 | 19 | $0 (2018) |
| Genentech USA, Inc. | $17,266 | 15 | $0 (2023) |
| Amgen Inc. | $14,951 | 12 | $0 (2022) |
| Genentech, Inc. | $12,300 | 14 | $0 (2023) |
| Pharmacyclics LLC, An AbbVie Company | $10,862 | 28 | $0 (2023) |
| Janssen Biotech, Inc. | $9,888 | 14 | $0 (2018) |
| Lilly USA, LLC | $8,790 | 7 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $49,243 | 37 | EMD Serono, Inc. ($11,340) |
| 2022 | $10,253 | 16 | Incyte Corporation ($2,998) |
| 2021 | $14,459 | 13 | GlaxoSmithKline, LLC. ($3,285) |
| 2020 | $17,078 | 9 | GlaxoSmithKline, LLC. ($4,930) |
| 2019 | $70,579 | 87 | EMD Serono, Inc. ($16,386) |
| 2018 | $77,217 | 101 | Novartis Pharmaceuticals Corporation ($11,919) |
| 2017 | $62,937 | 75 | Eli Lilly and Company ($16,205) |
All Payment Transactions
338 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2023 | Genentech USA, Inc. | Xolair (Biological) | Consulting Fee | Cash or cash equivalent | $4,415.00 | General |
| Category: Immunology | ||||||
| 12/10/2023 | Genentech USA, Inc. | Xolair (Biological) | Travel and Lodging | Cash or cash equivalent | $504.13 | General |
| Category: Immunology | ||||||
| 12/10/2023 | Genentech USA, Inc. | Xolair (Biological) | Travel and Lodging | Cash or cash equivalent | $303.97 | General |
| Category: Immunology | ||||||
| 12/10/2023 | Genentech USA, Inc. | Xolair (Biological) | Travel and Lodging | Cash or cash equivalent | $32.00 | General |
| Category: Immunology | ||||||
| 12/08/2023 | ViiV Healthcare Company | — | Consulting Fee | Cash or cash equivalent | $4,500.00 | General |
| 10/17/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,226.00 | General |
| 09/20/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Travel and Lodging | In-kind items and services | $906.00 | General |
| Category: ONCOLOGY | ||||||
| 09/20/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $58.37 | General |
| Category: ONCOLOGY | ||||||
| 09/20/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $54.30 | General |
| Category: ONCOLOGY | ||||||
| 09/20/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $10.18 | General |
| Category: ONCOLOGY | ||||||
| 09/20/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $10.18 | General |
| Category: ONCOLOGY | ||||||
| 09/19/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Travel and Lodging | In-kind items and services | $351.03 | General |
| Category: ONCOLOGY | ||||||
| 09/19/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $101.81 | General |
| Category: ONCOLOGY | ||||||
| 09/15/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Consulting Fee | Cash or cash equivalent | $3,030.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/15/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Travel and Lodging | Cash or cash equivalent | $488.63 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/15/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Travel and Lodging | Cash or cash equivalent | $238.26 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/09/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | — | Consulting Fee | Cash or cash equivalent | $4,112.50 | General |
| 09/09/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | — | Travel and Lodging | In-kind items and services | $237.38 | General |
| 09/09/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | — | Food and Beverage | In-kind items and services | $155.46 | General |
| 09/09/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | — | Travel and Lodging | Cash or cash equivalent | $150.43 | General |
| 09/09/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | — | Travel and Lodging | In-kind items and services | $32.00 | General |
| 09/09/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | — | Food and Beverage | In-kind items and services | $20.87 | General |
| 06/01/2023 | ITI, Inc. | CAPLYTA (Drug) | Consulting Fee | Cash or cash equivalent | $4,500.00 | General |
| Category: PSYCHIATRY | ||||||
| 06/01/2023 | ITI, Inc. | CAPLYTA (Drug) | Travel and Lodging | Cash or cash equivalent | $595.21 | General |
| Category: PSYCHIATRY | ||||||
| 06/01/2023 | ITI, Inc. | CAPLYTA (Drug) | Travel and Lodging | Cash or cash equivalent | $451.43 | General |
| Category: PSYCHIATRY | ||||||
About Dr. Gary Johnson, MD
Dr. Gary Johnson, MD is a Family Medicine healthcare provider based in Madison, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750300430.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Johnson, MD has received a total of $301,766 in payments from pharmaceutical and medical device companies, with $49,243 received in 2023. These payments were reported across 338 transactions from 40 companies. The most common payment nature is "Consulting Fee" ($219,932).
Ad
Practice Information
- Specialty Family Medicine
- Location Madison, WI
- Active Since 07/19/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1750300430
Products in Payments
- Bavencio (Drug) $15,120
- Xolair (Biological) $11,801
- DASOTRALINE (Drug) $10,707
- Imbruvica (Drug) $9,020
- Lucentis (Biological) $8,254
- TALTZ (Drug) $7,769
- Dasotraline (Drug) $6,550
- Trintellix (Drug) $6,426
- KEVZARA SARILUMAB INJECTION (Biological) $6,394
- CAPLYTA (Drug) $6,019
- SOTAGLIFLOZIN (Drug) $5,868
- Non-Covered Product (Drug) $5,754
- ADVATE (Biological) $5,374
- Tremfya (Drug) $5,253
- VYEPTI (Biological) $4,962
- Tymlos (Biological) $4,779
- REMICADE (Biological) $4,635
- Non-Covered $4,340
- Evobrutinib $4,050
- Axumin (Drug) $3,964
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Madison
Dr. Frederick Freitag, D.o, D.O
Family Medicine — Payments: $228,855
Family Medicine $228,855
Michael Ostrov, Md, MD
Family Medicine — Payments: $160,148
Family Medicine $160,148
Lewis Johnston, M.d, M.D
Family Medicine — Payments: $26,320
Family Medicine $26,320
James Bigham, Md, MD
Family Medicine — Payments: $26,208
Family Medicine $26,208
Dr. Peter Geleskie, M.d, M.D
Family Medicine — Payments: $22,887
Family Medicine $22,887
Bruce Black, M.d, M.D
Family Medicine — Payments: $21,035
Family Medicine $21,035